Global Information
회사소개 | 문의 | 비교리스트

HPV 검사와 PAP 검사 시장(2019-2025년)

HPV Testing and Pap Test Market 2019-2025

리서치사 Orion Market Research Pvt Ltd
발행일 2020년 06월 상품 코드 949644
페이지 정보 영문
가격
US $ 3,600 ₩ 4,254,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,672,000 Printable PDF (Enterprise License)


HPV 검사와 PAP 검사 시장(2019-2025년) HPV Testing and Pap Test Market 2019-2025
발행일 : 2020년 06월 페이지 정보 : 영문

세계의 HPV 검사와 PAP 검사 시장은 예측기간 중 크게 성장할 것으로 예상됩니다. HPV 검사와 PAP 검사 프로세스는 여성 자궁경부의 암과 전암 상태를 진단하는 프로세스를 수반합니다. 전암 상태는 인체유두종바이러스(HPV)에 의해 발생하는 세포 변화라고 이해되며, 이러한 이상의 치료가 빨리 실시되지 못할 경우 자궁경부암에 이를 가능성이 있습니다. HPV 검사는 자궁경부암의 향후 발증을 막기 위해 자궁경부 세포의 HPV를 발견하기 위해 행해집니다. 시장 성장에 기여하는 요인에는 세계에서 자궁경부암 증례가 증가하고 있는 점이 포함됩니다. 예를 들어 세계보건기구에 의하면 2018년에는 57만건의 새로운 증례수가 등록되고, 모든 여성 암환자 인구의 6.6%를 차지하고 있습니다.

지역적으로는 북미가 시장에서 큰 점유율을 차지할 것으로 예상됩니다. HPV 검사와 PAP 검사 시장 성장은 북미 지역에서 자궁경부암이 의심되는 여성 인구 증가에 의한 것입니다. 아시아태평양은 예측기간 중 시장에서 대폭적인 성장률을 나타낼 것으로 추정됩니다.

세계의 HPV 검사와 PAP 검사 시장에 대해 조사했으며, 시장 개요와 함께 검사 종류별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 보고서 개요

제2장 시장 개요와 인사이트

  • 조사 범위
  • 애널리스트의 인사이트와 현재 시장 동향
  • 규칙과 규제

제3장 경쟁 상황

  • 주요 전략 분석
  • 주요 기업 분석
    • Abbott Laboratories Inc.
    • F. Hoffmann-La Roche Ltd.
    • Becton, Dickinson and Co.
    • Qiagen NV
    • Quest Diagnostics Inc.

제4장 시장 결정요인

  • 시장 성장 촉진요인
  • 시장 성장 억제요인/과제
  • 시장 기회

제5장 시장 세분화

  • 검사 종류별 시장

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타
  • 기타 지역

제7장 기업 개요

  • Abbott Laboratories Inc.
  • Arbor Vita Corp.
  • Becton, Dickinson and Co.
  • BioMerieux SA
  • Cepheid Inc.
  • Diagcor Bioscience Inc. Ltd
  • Diagnostic Laboratory Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genera Biosystems Ltd.
  • GENOMICA SA
  • Greiner Bio-One International GmbH
  • Hologic, Inc.
  • HybriBio Ltd.
  • Laboratory Corp of America Holdings
  • Mikrogen Molekularbiologische Entwicklungs Gmbh
  • NURX Inc.
  • PreTect AS
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Seegene, Inc.
  • TAKARA SHUZO Co., Ltd.
KSM 20.08.03

LIST OF TABLES

  • 1. GLOBAL HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL HPV TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL PAP TESTMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL CO-TESTINGMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 6. NORTH AMERICANHPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 7. NORTH AMERICAN HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)
  • 8. EUROPEANHPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 9. EUROPEANHPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)
  • 10. ASIA-PACIFIC HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 11. ASIA-PACIFIC HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)
  • 12. REST OF THE WORLD HPV TESTING AND PAP TEST MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HPV TESTING AND PAP TEST MARKET SHARE BY TEST TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL HPV TESTING AND PAP TEST MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 3. US HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 4. CANADA HPV TESTING AND PAP TEST MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. UK HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 6. FRANCE HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 7. GERMANY HPV TESTING AND PAP TEST MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. ITALY HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 9. SPAIN HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ROE HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 11. INDIA HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 12. CHINA HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 13. JAPAN HPV TESTING AND PAP TESTMARKET SIZE, 2018-2025 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC HPV TESTING AND PAP TEST MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF THE WORLD HPV TESTING AND PAP TEST MARKET SIZE, 2018-2025 ($ MILLION)

Global HPV Testing and Pap Test Market Size, Share & Trends Analysis Report By Test Type (HPV Test, PAP Test, and Co-Testing), and Forecast 2019-2025

The global HPV testing and Pap test market are anticipated to grow significantly during the forecast period.HPV testing and Pap test process involve the process of diagnosing the cancers and precancers in the cervix of women. Precancers can be understood as cell changes that can be caused by the human papillomavirus (HPV) and if the treatment of these abnormal cannot be done on time, they can lead to cervical cancer. An HPV test is done to looks for HPV in cervical cells to prevent the future development of cervical cancer. The factor contributing to the growth of the market includes increasing cervical cancer cases across the globe. For instance, according to the World Health Organization, an estimated 570,000 new cases were registered in 2018 representing 6.6% of all female cancer population.

The HPV testing and Pap test market is segmented based on test type and application. Based on the test type, the market is sub-segmented into the HPV test, Pap test, and Co-testing. Pap test segment is anticipated to hold a significant share in the market. Further, researchers across the globe are conducting collaborative studies for discovering the advantages of combining the HPV and Pap tests for the early diagnosis reproductive tract cancer in women. This in tur, tend to drive the global HPV testing and Pap test market during the forecast period.

Geographically, the study of the global HPV testing and Pap test market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. North America is expected to contribute a significant share in the market. The growth in HPV testing and the Pap test market is owing to an increase in the number of the female population that are suspect of cervical cancer in the North American region. Asia-Pacific is estimated to exhibit a significant growth rate in the global HPV testing and Pap test market during the forecast period.

Some of thekey players of the global HPV testing and Pap test market includeAbbott Laboratories Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Co., Qiagen NV, Quest Diagnostics Inc., Quest Diagnostics Inc., Seegene, Inc., TAKARA SHUZO Co., Ltd., and others.

Research Methodology

The market study of the global HPV testing and Pap testmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the pharmaceutical industry, hospitals& clinics, diagnostic centers,medical device companies, government organizations, regulatory bodies, and other related organizations for overall market analysis and competitive analysis.The report provides an in-depth analysis of market size, products offered by the company, and future growth opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. GlobalHPV Testing and Pap TestMarket Research and Analysis by Test Type

The Report Covers:

  • Comprehensive research methodology of the global HPV testing and Pap testmarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global HPV testing and Pap testmarket.
  • Insights about market determinants which are stimulating the global HPV testing and Pap testmarket.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Strategy Analysis
  • 3.2. Key Company Analysis
    • 3.2.1. Abbott Laboratories Inc.
      • 3.2.1.1. Overview
      • 3.2.1.2. Financial Analysis
      • 3.2.1.3. SWOT Analysis
      • 3.2.1.4. Recent Developments
    • 3.2.2. F. Hoffmann-La Roche Ltd.
      • 3.2.2.1. Overview
      • 3.2.2.2. Financial Analysis
      • 3.2.2.3. SWOT Analysis
      • 3.2.2.4. Recent Developments
    • 3.2.3. Becton, Dickinson and Co.
      • 3.2.3.1. Overview
      • 3.2.3.2. Financial Analysis
      • 3.2.3.3. SWOT Analysis
      • 3.2.3.4. Recent Developments
    • 3.2.4. Qiagen NV
      • 3.2.4.1. Overview
      • 3.2.4.2. Financial Analysis
      • 3.2.4.3. SWOT Analysis
      • 3.2.4.4. Recent Developments
    • 3.2.5. Quest Diagnostics Inc.
      • 3.2.5.1. Overview
      • 3.2.5.2. Financial Analysis
      • 3.2.5.3. SWOT Analysis
      • 3.2.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints/Challenges
    • 4.1. Opportunities

5. Market Segmentation

  • 5.1. HPV testing and Pap test Market by Test Type
      • 5.1.1.1. HPV Test
      • 5.1.1.2. PAP Test
      • 5.1.1.3. Co-Testing

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. Arbor Vita Corp.
  • 7.3. Becton, Dickinson and Co.
  • 7.4. BioMerieux SA
  • 7.5. Cepheid Inc.
  • 7.6. Diagcor Bioscience Inc. Ltd
  • 7.7. Diagnostic Laboratory Services, Inc.
  • 7.8. F. Hoffmann-La Roche Ltd.
  • 7.9. Genera Biosystems Ltd.
  • 7.10. GENOMICA SA
  • 7.11. Greiner Bio-One International GmbH
  • 7.12. Hologic, Inc.
  • 7.13. HybriBio Ltd.
  • 7.14. Laboratory Corp of America Holdings
  • 7.15. Mikrogen Molekularbiologische Entwicklungs Gmbh
  • 7.16. NURX Inc.
  • 7.17. PreTect AS
  • 7.18. QIAGEN NV
  • 7.19. Quest Diagnostics Inc.
  • 7.20. Seegene, Inc.
  • 7.21. TAKARA SHUZO Co., Ltd.
Back to Top
전화 문의
F A Q